Commentary on The Gene Master Regulators GMR Approach Provides Legitimate Targets for Personalized, Time-Sensitive Cancer Gene Therapy
Year: 2019
Type: editorial
Abstract: For decades, the scientific community tried hard to identify the gene biomarkers whose mutations or regulations cause (better say are associated with) specific forms of cancer. For instance, the September 17th 2019 release of the Genomic Data Commons Data Portal includes 3,142,246 mutations detected in 22,872 genes sequenced from 37,075 cases of cancers localized in 67 primary sites. The hope was (and still is) to treat cancer by restoring the normal sequence or/and expression level of the biomarker(s).
Source: Journal of Cancer Immunology
Author: Dumitru Andrei Iacobas
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: hybrid
OpenAlex ID: W2994750434